| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 2 |
| 1 | RISANKIZUMAB-RZAA | 2 |
| 2 | ACETAMINOPHEN | 1 |
| 3 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 1 |
| 4 | ALBUTEROL | 1 |
| 5 | ALBUTEROL SULFATE | 1 |
| 6 | ASPIRIN | 1 |
| 7 | ASPIRIN 325 MG | 1 |
| 8 | ASPIRIN 81 MG | 1 |
| 9 | CARISOPRODOL | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COAGULATION FACTOR IX RECOMBINANT HUMAN | 1 | 0.0009 |
| 1 | COAGULATION FACTOR VIIA (RECOMBINANT) | 1 | 0.0004 |
| 2 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 3 | FREMANEZUMAB-VFRM | 1 | 0.0001 |
| 4 | VELPATASVIR AND SOFOSBUVIR | 1 | 0.0001 |
| 5 | CARISOPRODOL | 1 | 0.0001 |
| 6 | VITAMIN E | 1 | 0.0000 |
| 7 | GUSELKUMAB | 1 | 0.0000 |
| 8 | ETONOGESTREL | 1 | 0.0000 |
| 9 | DIAZEPAM ORAL | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-23 Antagonist [EPC] | 3 | 0.0000 |
| 1 | Muscle Relaxant [EPC] | 1 | 0.0000 |
| 2 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Interferon beta [EPC] | 1 | 0.0000 |
| 5 | Expectorant [EPC] | 1 | 0.0000 |
| 6 | Progestin [EPC] | 1 | 0.0000 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 3 | 0.0000 |
| 8 | Vitamin C [EPC] | 1 | 0.0000 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 1 | 0.0000 |